Recombinant EGFR (Zalutumumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-EGFR (Zalutumumab Biosimilar) antibody (ABIN7487875) specifically detects EGFR (Zalutumumab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7487875
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant EGFR (Zalutumumab Biosimilar) antibody (ABIN7487875)
Target
EGFR (Zalutumumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This EGFR (Zalutumumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Zalutumumab Biosimilar - Anti-EGFR mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- EGFR (Zalutumumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
HuMax-EGFr
Zalutumumab (proposed trade name HuMax-EGFR) is a high affinity, completely human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR, also known as ErbB1/HER1). It is developed by Genmab and designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. Zalutumumab is derived from transgenic mice immunized with A431-derived EGFR. -
CAS-No
- 667901-13-5
Target
-
You are here:
